Treatment with dapagliflozin reduced the risk of death or worsening heart failure by 28% compared with standard of care. Dapagliflozin reduced the risk of death or worsening heart failure (HF ...
Dapagliflozin is indicated for both type 2 diabetes and heart failure. It can do the following: improve management of blood sugar and reduce the risk of hospitalization for heart failure in adults ...
At close: April 4 at 4:00:02 PM EDT ...
Our research The gastrointestinal (GI) epidemiology group focus on research on GI organs and diseases. Most of that research is based on the ESPRESSO study, which you can read more about on a separate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback